6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)-ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, S-((3S)-TETRAHYDRO-2-OXO-3-FURANYL) ESTER, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-
UNII 97M3221V6B
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic Acid, S-((3s)-tetrahydro-2-oxo-3-furanyl) Ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 97M3221V6B.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 192056-77-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C28H34F2O7S POTREZAYKLAUSX-PIOZOLAZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-androsta-1,4-diene-17-carbothioic Acid, S-((3s)-tetrahydro-2-oxo-3-furanyl) Ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.